GFAP and Parkinson disease: These processes suppress innate protective astrocytic responses and enable further neuronal damage.41,43 In a recent post-mortem study in advanced Parkinson’s disease,43 researchers found a negative correlation between levels of α-synuclein accumulation and markers of astrogliosis, including the GFAP.